Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Colorectal Neoplasms 12Breast Neoplasms 12Pain 11Neoplasms 10Pain, Postoperative 9Prostatic Neoplasms 7Lung Neoplasms 6Agnosia 6Colonic Neoplasms 5Neuralgia 4Keratosis, Actinic 4Cancer Pain 4Liver Neoplasms 3Leiomyoma 3Head and Neck Neoplasms 3Chronic Pain 3Thyroid Neoplasms 2Stomach Neoplasms 2Pilonidal Sinus 2Oropharyngeal Neoplasms 2Neuroma 2Neoplasm Metastasis 2Myofibroma 2Inflammatory Bowel Diseases 2Ileus 2Diverticulitis 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

Surveys and Questionnaires 2Imatinib Mesylate 2talimogene laherparepvec 1pirfenidone 1nilotinib 1mirdametinib 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1Sunitinib 1Sirolimus 1Sevoflurane 1Propofol 1Percutaneous Collagen Induction 1Nitrous Oxide 1Lidocaine 1Lasers, Solid-State 1Lasers 1Glycopyrrolate 1Dexmedetomidine 1Blood Specimen Collection 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurofibromatoses × Lidocaine × Clear all
NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡